• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致836例前庭神经鞘瘤初始保守治疗方案改变的临床预测因素。

Clinical Predictors Leading to Change of Initial Conservative Treatment of 836 Vestibular Schwannomas.

作者信息

Kleijwegt Maarten, Bettink Floris, Malessy Martijn, Putter Hein, van der Mey Andel

机构信息

Department of ENT, Leiden University Medical Center, Leiden, The Netherlands.

Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

J Neurol Surg B Skull Base. 2020 Feb;81(1):15-21. doi: 10.1055/s-0039-1678708. Epub 2019 Feb 4.

DOI:10.1055/s-0039-1678708
PMID:32021745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6996999/
Abstract

This study was aimed to determine the role of clinical presentation and tumor characteristics in vestibular schwannoma (VS) at diagnosis, initially treated with conservative management.  The study was designed as a retrospective chart review.  The study was prepared at national tertiary referral center for VS patients.  A total of 836 VS patients, initially treated conservatively, were included.  Patient characteristics: age at diagnosis, gender, frequency, and duration of, hearing loss, tinnitus, balance disorder (unsteadiness, dizziness, and vertigo), respectively; and tumor characteristics: laterality, growth, cystic component, and location were analyzed in relation to tumor size at diagnosis and change in treatment strategy.  In total, 169 (20%) patients had a change in treatment strategy. Factors at diagnosis that had a high influence on intervention were a short duration of hearing loss (hazard ratio [HR]: 4.8,  < 0.001) and cystic tumors (HR = 2.6,  < 0.001). Balance disorders and extracanalicular (EC) tumor location have a medium influence on intervention (HR = 1.6,  < 0.01). Tumour growth was seen in 55% of the intervention group; we found a significant correlation with a short duration of hearing loss. Cystic VS was significantly higher between the medium and large tumors, 24.3% and 38.1%. (  = 0.001), respectively.  Patients with a short duration of hearing loss, balance disorders, EC located tumors, and cystic tumors have a significantly higher chance of a change in treatment strategy. Large tumor size at diagnosis and a cystic component were related to age > 65 years at diagnosis.

摘要

本研究旨在确定临床表现和肿瘤特征在前庭神经鞘瘤(VS)诊断时的作用,这些VS患者最初采用保守治疗。 本研究设计为回顾性病历审查。 该研究在国家三级VS患者转诊中心进行。 总共纳入了836例最初接受保守治疗的VS患者。 分析了患者特征:诊断时的年龄、性别、听力损失的频率和持续时间、耳鸣、平衡障碍(不稳、头晕和眩晕);以及肿瘤特征:患侧、生长情况、囊性成分和位置,并与诊断时的肿瘤大小和治疗策略的变化相关联。 总共有169例(20%)患者的治疗策略发生了变化。诊断时对干预有高度影响的因素是听力损失持续时间短(风险比[HR]:4.8,<0.001)和囊性肿瘤(HR = 2.6,<0.001)。平衡障碍和外耳道外(EC)肿瘤位置对干预有中等影响(HR = 1.6,<0.01)。在干预组中,55%的患者出现肿瘤生长;我们发现其与听力损失持续时间短有显著相关性。中等大小和大肿瘤中的囊性VS分别显著更高,为24.

相似文献

1
Clinical Predictors Leading to Change of Initial Conservative Treatment of 836 Vestibular Schwannomas.导致836例前庭神经鞘瘤初始保守治疗方案改变的临床预测因素。
J Neurol Surg B Skull Base. 2020 Feb;81(1):15-21. doi: 10.1055/s-0039-1678708. Epub 2019 Feb 4.
2
Comparison of two radiologic methods for measuring the size and growth rate of extracanalicular vestibular schwannomas.两种用于测量外耳道前庭神经鞘瘤大小及生长速率的放射学方法的比较。
Am J Otol. 2000 Sep;21(5):716-21.
3
Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.前庭神经鞘瘤的保守治疗:临床和生活质量结果的随访研究。
Otol Neurotol. 2009 Oct;30(7):968-74. doi: 10.1097/MAO.0b013e3181b4e3c9.
4
Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge.前庭神经鞘瘤的诊断与治疗——一项跨学科挑战。
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017 Dec 18;16:Doc03. doi: 10.3205/cto000142. eCollection 2017.
5
[Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].[前庭神经鞘瘤的诊断与管理——一项跨学科挑战]
Laryngorhinootologie. 2017 Apr;96(S 01):S152-S182. doi: 10.1055/s-0042-122386. Epub 2017 Oct 16.
6
Cochleovestibular symptoms related to the site of vestibular schwannoma.与前庭神经鞘瘤部位相关的耳蜗前庭症状。
Acta Otolaryngol Suppl. 2000;543:14-6. doi: 10.1080/000164800453829.
7
Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.观察564例前庭神经鞘瘤的单机构经验:与肿瘤生长相关的因素
Otol Neurotol. 2016 Dec;37(10):1630-1636. doi: 10.1097/MAO.0000000000001219.
8
Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation.1000例前庭神经鞘瘤(听神经瘤)的管理:临床表现
Neurosurgery. 1997 Jan;40(1):1-9; discussion 9-10. doi: 10.1097/00006123-199701000-00001.
9
Conservative management of vestibular schwannoma: expectations based on the length of the observation period.前庭神经鞘瘤的保守治疗:基于观察期时长的预期
Otol Neurotol. 2014 Aug;35(7):1258-65. doi: 10.1097/MAO.0000000000000285.
10
Hearing Loss Progresses Faster in Patients With Growing Intracanalicular Vestibular Schwannomas.内耳道内前庭神经鞘瘤不断生长的患者听力损失进展更快。
Otol Neurotol. 2016 Oct;37(9):1442-8. doi: 10.1097/MAO.0000000000001190.

引用本文的文献

1
Emerging strategies for the prediction of behaviour, growth, and treatment response in vestibular schwannoma.预测前庭神经鞘瘤行为、生长及治疗反应的新兴策略。
Acta Neurochir (Wien). 2025 Apr 22;167(1):116. doi: 10.1007/s00701-025-06522-7.
2
Untreated Vestibular Schwannoma: Analysis of the Determinants of Growth.未治疗的前庭神经鞘瘤:生长决定因素分析
Cancers (Basel). 2024 Nov 4;16(21):3718. doi: 10.3390/cancers16213718.
3
Which Epidemiological Characteristics Drive Decision Making in the Management of Patients with Vestibular Schwannoma?哪些流行病学特征驱动前庭神经鞘瘤患者管理中的决策制定?
Biomedicines. 2023 Jan 25;11(2):340. doi: 10.3390/biomedicines11020340.
4
[Clinical characteristics of acoustic neuroma patients with normal hearing].听力正常的听神经瘤患者的临床特征
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec;36(12):897-901. doi: 10.13201/j.issn.2096-7993.2022.12.002.

本文引用的文献

1
Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma.伽玛刀放射外科治疗散发性前庭神经鞘瘤后,预处理生长率作为肿瘤控制的预测指标。
J Neurosurg. 2017 Aug;127(2):380-387. doi: 10.3171/2016.5.JNS153013. Epub 2016 Nov 25.
2
Real Incidence of Vestibular Schwannoma? Estimations From a National Registry.前庭神经鞘瘤的实际发病率?来自国家登记处的估计。
Otol Neurotol. 2016 Oct;37(9):1411-7. doi: 10.1097/MAO.0000000000001169.
3
Perfusion magnetic resonance imaging provides additional information as compared to anatomical imaging for decision-making in vestibular schwannoma.与解剖成像相比,灌注磁共振成像为前庭神经鞘瘤的决策提供了额外信息。
Eur J Radiol Open. 2016 Jun 15;3:127-33. doi: 10.1016/j.ejro.2016.05.005. eCollection 2016.
4
Conservative management of vestibular schwannoma: Predictors of growth and hearing.前庭神经鞘瘤的保守治疗:生长和听力的预测因素
Laryngoscope. 2015 Sep;125(9):2163-8. doi: 10.1002/lary.25159. Epub 2015 Feb 3.
5
Conservative management of vestibular schwannoma: expectations based on the length of the observation period.前庭神经鞘瘤的保守治疗:基于观察期时长的预期
Otol Neurotol. 2014 Aug;35(7):1258-65. doi: 10.1097/MAO.0000000000000285.
6
Outcome after translabyrinthine surgery for vestibular schwannomas: report on 1244 patients.前庭神经鞘瘤经迷路手术后的结果:1244例患者的报告。
J Neurol Surg B Skull Base. 2012 Jun;73(3):168-74. doi: 10.1055/s-0032-1301403.
7
Epidemiology and natural history of vestibular schwannomas.前庭神经鞘瘤的流行病学与自然史
Otolaryngol Clin North Am. 2012 Apr;45(2):257-68, vii. doi: 10.1016/j.otc.2011.12.008. Epub 2012 Feb 28.
8
Prediction of vestibular schwannoma growth: a novel rule based on clinical symptomatology.前庭神经鞘瘤生长的预测:基于临床症状学的新规则
Ann Otol Rhinol Laryngol. 2011 Dec;120(12):807-13. doi: 10.1177/000348941112001206.
9
Facial nerve function after vestibular schwannoma surgery.前庭神经鞘瘤手术后的面神经功能。
J Neurosurg. 2011 Oct;115(4):820-6. doi: 10.3171/2011.5.JNS101597. Epub 2011 Jun 17.
10
True incidence of vestibular schwannoma?前庭神经鞘瘤的真实发病率?
Neurosurgery. 2010 Nov;67(5):1335-40; discussion 1340. doi: 10.1227/NEU.0b013e3181f22660.